The early treatment for retinopathy of prematurity study: structural findings at age 2 years

被引：70

作者：

Good, William V. ^{[1
]}

Hardy, Robert J. ^{[1
]}

Dobson, Velma ^{[1
]}

Palmer, Earl A. ^{[1
]}

Phelps, Dale L. ^{[1
]}

Quintos, Michelle ^{[1
]}

Tung, Betty ^{[1
]}

Madan, Ashima ^{[1
]}

Ball, M. Bethany ^{[1
]}

Hartsell, Patricia N. ^{[1
]}

Inguillo, Dottie ^{[1
]}

Gaynon, Michael ^{[1
]}

Alcorn, Deborah ^{[1
]}

Good, William V. ^{[1
]}

Ornitz, Donna ^{[1
]}

Gancasz, Judith ^{[1
]}

Durand, David ^{[1
]}

Smith, Gordon ^{[1
]}

Shapiro, Michael ^{[1
]}

Garcia, Yesenia ^{[1
]}

Genio, Maria ^{[1
]}

Bloom, Jeffrey N. ^{[1
]}

Kaufman, Lawrence ^{[1
]}

Lai, Wico Waikwan ^{[1
]}

Miller, Marilyn ^{[1
]}

Neely, Daniel ^{[1
]}

Hynes, Elizabeth A. ^{[1
]}

Lemons, James ^{[1
]}

Plager, David ^{[1
]}

Sondhi, Naval ^{[1
]}

Sprunger, Derek ^{[1
]}

Rychwalski, Paul J. ^{[1
]}

Whittington, Greg K. ^{[1
]}

Fishman, Peggy H. ^{[1
]}

Gordon, Robert A. ^{[1
]}

Neff, Deborah S. ^{[1
]}

Babel, Douglas B. ^{[1
]}

Diamond, James G. ^{[1
]}

Gill, William L. ^{[1
]}

Steidl, Scott M. ^{[1
]}

Hutcheson, Kelly A. ^{[1
]}

Powdrill, Kevin ^{[1
]}

Jones, Eric ^{[1
]}

Preslan, Mark W. ^{[1
]}

Repka, Michael X. ^{[1
]}

Shepard, Jennifer A. ^{[1
]}

Donahue, Pamela ^{[1
]}

Aucott, Susan W. ^{[1
]}

Collins, Mary Louise Z. ^{[1
]}

Gilmore, Maureen M. ^{[1
]}

机构：

[1] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA

来源：

BRITISH JOURNAL OF OPHTHALMOLOGY | 2006年 / 90卷 / 11期

关键词：

D O I：

10.1136/bjo.2006.098582

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Objective: To determine whether earlier treatment of high-risk, prethreshold retinopathy of prematurity (ROP) improves retinal structural outcome at 2 years of age. Methods: Infants with bilateral high-risk prethreshold ROP had one eye randomly assigned to treatment with peripheral retinal ablation. The fellow eye was managed conventionally, and either treated at threshold ROP or observed if threshold was never reached. In patients with asymmetrical disease, the high-risk, prethreshold eye was randomised to earlier treatment or to conventional management. At 2 years of age, children were examined comprehensively by certified ophthalmologists to determine structural outcomes for their eyes. For the purposes of this study, an unfavourable structural outcome was defined as (1) a posterior retinal fold involving the macula, (2) a retinal detachment involving the macula or ( 3) retrolental tissue or ''mass'' obscuring the view of the posterior pole. Results of the 2-year examination were compared with those from the 9 months examination. Results: Data were available on 339 of 374 (90.6%) surviving children. Unfavourable structural outcomes were reduced from 15.4% in conventionally managed eyes to 9.1% in earlier-treated eyes (p = 0.002) at 2 years of age. Ophthalmic side effects (excluding retinal structure) from the ROP or its treatment were similar in the earlier-treated eyes and the conventionally managed eyes. Conclusion: The benefit of earlier treatment of high-risk prethreshold ROP on retinal structure endures to 2 years of age, and is not counterbalanced by any known side effect caused by earlier intervention. Earlier treatment improves the chance for long-term favourable retinal structural outcome in eyes with high-risk prethreshold ROP. Long-term follow-up is planned to determine structural and functional outcomes at 6 years of age.

引用

页码：1378 / 1382

页数：5

共 12 条

[1]

[Anonymous], 1990, ARCH OPHTHALMOL-CHIC, V108, P1408

[2]

Elsas FJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1110

[3]

Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233

[4] The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity - In reply [J].

Good, WV ;

Hardy, RJ .

ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (03) :409-410

[5]

Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684

[6] The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study [J].

Good, WV .

PEDIATRICS, 2005, 116 (01) :15-23

[7] Risk analysis of prethreshold retinopathy of prematurity [J].

Hardy, RJ ;

Palmer, EA ;

Dobson, V ;

Summers, CG ;

Phelps, DL ;

Quinn, GE ;

Good, WV ;

Tung, B .

ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (12) :1697-1701

[8] Multicenter trial of early treatment for retinopathy of prematurity: study design [J].

Hardy, RJ ;

Good, WV ;

Dobson, V ;

Palmer, EA ;

Phelps, DL ;

Quintos, M ;

Tung, B ;

Madan, A ;

Gaynon, M ;

Ball, B ;

Hartsell, PN ;

Inguillo, D ;

Alcorn, D ;

Good, WV ;

Ornitz, D ;

Stevenson, D ;

Good, WV ;

Hubbard, M ;

Lee, J ;

Brinton, D ;

Day, S ;

Durand, D ;

Fredrick, D ;

Phibbs, RH ;

Schwartz, D ;

Slagle, T ;

Smith, G ;

Shapiro, M ;

Garcia, Y ;

Genio, M ;

Parker, J ;

Rupar, B ;

Becker, H ;

Bhat, R ;

Bloom, JN ;

Corsino, JV ;

Kaufman, L ;

Lai, WW ;

Pulido, J ;

Raju, TNK ;

Shukla, AK ;

Ticho, B ;

Vidyasagar, D ;

Lemons, J ;

Neely, D ;

Appel, DD ;

Hynes, EA ;

Wright, L ;

Plager, D ;

Sondhi, N .

CONTROLLED CLINICAL TRIALS, 2004, 25 (03) :311-325

[9]

PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471

[10]

Palmer EA, 2005, ARCH OPHTHALMOL-CHIC, V123, P311

← 1 2 →